Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Pretreatment With Magnesium Oxide Followed by Letrozole on Ovarian Response in Subfertile Women With Insulin Resistant Polycystic Ovarian Syndrome in Comparison to Letrozole Alone

NCT07766590 is registered in ClinicalTrials.gov with Bangladesh Medical University as lead sponsor.

NCT NCT07766590
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07766590 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Pretreatment With Magnesium Oxide Followed by Letrozole on Ovarian Response in Subfertile Women With Insulin Resistant Polycystic Ovarian Syndrome in Comparison to Letrozole Alone
Lead sponsor
Bangladesh Medical University
Phase
Not applicable
Overall status
Completed
Start date
June 1, 2025
Completion date
May 28, 2026
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insulin resistant pcos